| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
171,731 | 181,458 | 216,752 | 223,530 | 210,067 |
| Cost of Revenue
|
-74,356 | -80,159 | -105,533 | -105,547 | -101,337 |
|
Gross Profit
|
97,375 | 101,299 | 111,219 | 117,983 | 108,730 |
| Selling, General and Administrative Expenses
|
-98,932 | -99,727 | -121,824 | -115,806 | -110,606 |
| Depreciation, Amortization and Depletion
|
-21,588 | -21,390 | -31,225 | -25,851 | -19,470 |
| Provision Expense/Write-Back
|
1,216 | 1,216 | 156 | -- | -- |
| Other Income/Expense, Operating
|
-3,661 | -5,072 | -9,827 | -4,495 | -8,948 |
|
Operating Income/Expenses
|
-122,965 | -124,973 | -162,720 | -146,152 | -139,024 |
|
Total Operating Profit/Loss
|
-25,590 | -23,674 | -51,501 | -28,169 | -30,294 |
| Total Net Finance Income/Expense
|
-1,842 | -1,787 | -240 | -418 | -2,465 |
| Net Investment Income
|
-78 | -78 | -385 | -2 | -432 |
| Irregular Income/Expenses
|
-1,731 | -1,731 | -33,664 | -19,552 | -11,529 |
|
Non-Operating Income/Expenses, Total
|
-3,651 | -3,596 | -34,289 | -19,972 | -14,426 |
|
Pretax Income
|
-30,138 | -28,167 | -85,790 | -48,141 | -44,718 |
|
Provision for Income Tax
|
-6 | -1 | 931 | 256 | -209 |
|
Net Income from Continuing Operations
|
-30,144 | -28,168 | -84,859 | -47,885 | -44,927 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-30,144 | -28,168 | -84,859 | -47,884 | -44,927 |
|
Net Income after Non-Controlling/Minority Interests
|
-30,144 | -28,168 | -84,859 | -47,884 | -44,927 |
|
Net Income Available to Common Stockholders
|
-30,144 | -28,168 | -84,859 | -47,884 | -44,927 |
|
Diluted Net Income Available to Common Stockholders
|
-30,144 | -28,168 | -84,859 | -47,884 | -44,927 |
| Basic EPS
|
-0.89 | -0.84 | -2.56 | -1.45 | -1.33 |
| Diluted EPS
|
-0.89 | -0.84 | -2.56 | -1.45 | -1.33 |
|
Basic Weighted Average Shares Outstanding
|
33,795.4290 | 33,404 | 33,166 | 32,980 | 33,856 |
|
Diluted Weighted Average Shares Outstanding
|
33,795.4290 | 33,404 | 33,166 | 32,980 | 33,970.5130 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-28,296 | -26,380 | -85,550 | -47,723 | -42,253 |
|
EBITDA
|
-4,757 | -4,074 | -29,463 | -21,872 | -22,783 |
|
Normalized EBITDA
|
80 | 3,002 | -5,801 | 900 | -8,289 |
|
Normalized Income
|
-26,032.5500 | -27,350.3000 | -46,075.4961 | -18,117.1518 | -31,337.3500 |
|
Total Unusual Items
|
4,837 | 962 | 39,209 | 29,927 | 15,607 |
12/31/2022 - 7/2/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade